Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,371 public trials 203 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Recruiting

Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .

NCT07191249

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Rambam Health Care Campus Haifa, Israel
  • Shaare Zedek Medical Center Jerusalem, Israel
  • The Hadassah University Hospital-Ein Kerem Jerusalem, Israel
  • Tel Aviv Sourasky Medical Center (TASMC) - Ichilov Tel Aviv, Israel
View Trial Details
Recruiting

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

NCT05389293

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Georgetown University (Data Collection Only) Washington D.C., District of Columbia, United States
  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities Basking Ridge, New Jersey, United States
  • Hackensack Meridian Health (Data collection only) Hackensack, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

NCT06542250

Conditions
B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site Hackensack, New Jersey, United States
View all 31 locations
View Trial Details
Recruiting

STimulation to Activate RespIration

NCT06832306

Conditions
AHRF, ARDS (Moderate or Severe), Hemic and Lymphatic Diseases, +10 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Louisiana State University Health Sciences Shreveport, Louisiana, United States
  • Wake Forest University School of Medicine Winston-Salem, North Carolina, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

NCT06533579

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
View Trial Details
Recruiting

Pain With Dementia

NCT06854718

Conditions
Brain Diseases, Central Nervous System Diseases, Dementia, +19 more
Locations
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686

Conditions
Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +43 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • St. Joseph Hospital Center for Cancer Prevention and Treatment Orange, California, United States
View all 175 locations
View Trial Details

Related conditions